Free Trial

Oppenheimer (NYSE:OPY) Stock Rating Lowered by Wall Street Zen

Oppenheimer logo with Finance background

Key Points

  • Oppenheimer (NYSE:OPY) has been downgraded from a "buy" to a "hold" rating by analysts at Wall Street Zen, indicating a shift in market sentiment regarding the company's stock.
  • Shares of Oppenheimer have fallen 3.3%, opening at $73.31, with a notable 52-week low of $47.39 and high of $77.83.
  • Insider transaction activity includes Director Paul M. Friedman selling 3,500 shares, reducing his stake by 14.58%, while institutional investors hold approximately 32.26% of the stock.
  • Five stocks to consider instead of Oppenheimer.

Wall Street Zen lowered shares of Oppenheimer (NYSE:OPY - Free Report) from a buy rating to a hold rating in a research note published on Saturday.

Oppenheimer Stock Up 1.8%

Shares of NYSE OPY traded up $1.33 during trading on Friday, reaching $74.61. 53,673 shares of the company traded hands, compared to its average volume of 43,166. The firm has a 50 day simple moving average of $66.89 and a 200-day simple moving average of $63.77. Oppenheimer has a 52-week low of $47.39 and a 52-week high of $77.83. The stock has a market capitalization of $785.22 million, a PE ratio of 9.68 and a beta of 1.24.

Oppenheimer (NYSE:OPY - Get Free Report) last posted its earnings results on Friday, August 1st. The financial services provider reported $1.91 EPS for the quarter. The business had revenue of $373.18 million during the quarter. Oppenheimer had a net margin of 5.88% and a return on equity of 10.26%.

Oppenheimer Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, August 15th. Oppenheimer's dividend payout ratio (DPR) is presently 9.34%.

Insider Transactions at Oppenheimer

In other Oppenheimer news, Director Paul M. Friedman sold 3,500 shares of the business's stock in a transaction dated Monday, June 9th. The stock was sold at an average price of $63.32, for a total transaction of $221,620.00. Following the completion of the sale, the director directly owned 20,500 shares in the company, valued at $1,298,060. The trade was a 14.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 34.25% of the company's stock.

Institutional Trading of Oppenheimer

Large investors have recently added to or reduced their stakes in the business. Boston Partners raised its position in Oppenheimer by 457.7% in the first quarter. Boston Partners now owns 71,568 shares of the financial services provider's stock worth $4,268,000 after acquiring an additional 58,735 shares during the period. Royce & Associates LP raised its holdings in Oppenheimer by 114.8% in the 1st quarter. Royce & Associates LP now owns 80,551 shares of the financial services provider's stock worth $4,803,000 after purchasing an additional 43,050 shares during the period. Invesco Ltd. lifted its position in Oppenheimer by 864.7% during the first quarter. Invesco Ltd. now owns 41,596 shares of the financial services provider's stock valued at $2,480,000 after purchasing an additional 37,284 shares in the last quarter. American Century Companies Inc. lifted its position in Oppenheimer by 17.2% during the first quarter. American Century Companies Inc. now owns 227,389 shares of the financial services provider's stock valued at $13,559,000 after purchasing an additional 33,433 shares in the last quarter. Finally, Boothbay Fund Management LLC bought a new stake in Oppenheimer during the fourth quarter valued at about $1,717,000. 32.26% of the stock is currently owned by institutional investors.

About Oppenheimer

(Get Free Report)

Oppenheimer Holdings Inc operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia. The company provides brokerage services covering corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts; financial and wealth planning services; and margin lending services.

See Also

Should You Invest $1,000 in Oppenheimer Right Now?

Before you consider Oppenheimer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oppenheimer wasn't on the list.

While Oppenheimer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines